Philip W Shaul Selected Research

low density lipoprotein receptor-related protein 8

1/2021	Apolipoprotein E receptor 2 deficiency decreases endothelial adhesion of monocytes and protects against autoimmune encephalomyelitis.
10/2018	Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium.
3/2016	ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice.
1/2016	Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis.
10/2014	Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.
9/2014	Genetic variants of ApoE and ApoER2 differentially modulate endothelial function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip W Shaul Research Topics

Disease

12	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 11/2005
10	Atherosclerosis 01/2019 - 10/2002
8	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2008
6	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021 - 01/2011
6	Thrombosis (Thrombus) 10/2018 - 06/2006
5	Insulin Resistance 05/2020 - 03/2013
5	Obesity 05/2020 - 08/2014
5	Neoplasms (Cancer) 11/2018 - 04/2011
5	Lung Diseases (Lung Disease) 01/2006 - 05/2003
4	Hypertension (High Blood Pressure) 12/2019 - 01/2002
4	Vascular Diseases (Vascular Disease) 07/2014 - 02/2003
3	Pregnancy Complications 03/2016 - 01/2011
3	Type 2 Diabetes Mellitus (MODY) 01/2016 - 06/2009
3	Neointima 01/2015 - 09/2014
3	Bronchopulmonary Dysplasia 07/2011 - 01/2006
3	Premature Birth (Birth, Premature) 02/2011 - 03/2005
2	Inflammation (Inflammations) 01/2021 - 01/2018
2	Infarction (Infarctions) 11/2018 - 01/2017
2	Hemorrhage 09/2017 - 02/2011
2	Body Weight (Weight, Body) 08/2014 - 02/2011
2	Patent Ductus Arteriosus 03/2011 - 12/2005
2	Pneumonia (Pneumonitis) 03/2011 - 03/2009
2	Electric Injuries 05/2007 - 01/2006
2	Vascular System Injuries 08/2003 - 10/2002
1	Encephalomyelitis (Myeloencephalitis) 01/2021
1	Pre-Eclampsia (Preeclampsia) 01/2021
1	Myocardial Infarction 01/2019
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2018
1	Neuroinflammatory Diseases 11/2018
1	Stroke (Strokes) 11/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Weight Gain 01/2018
1	Infections 10/2017
1	Reperfusion Injury 01/2017
1	Glut1 Deficiency Syndrome 06/2015
1	Atherosclerotic Plaque (Atheroma) 05/2015
1	Hypertrophy 10/2014

Drug/Important Bio-Agent (IBA)

9	Estrogens (Estrogen)FDA Link 11/2018 - 10/2002
8	C-Reactive ProteinIBA 01/2016 - 11/2005
7	CholesterolIBA 03/2022 - 06/2006
7	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 03/2013
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2011 - 02/2003
6	low density lipoprotein receptor-related protein 8IBA 01/2021 - 09/2014
6	Estradiol (Delestrogen)FDA LinkGeneric 11/2018 - 03/2009
6	Antiphospholipid AntibodiesIBA 10/2018 - 01/2011
6	Nitric Oxide Synthase (NO Synthase)IBA 02/2015 - 02/2003
5	Estrogen ReceptorsIBA 03/2022 - 10/2007
5	HDL CholesterolIBA 05/2015 - 02/2004
4	27-hydroxycholesterolIBA 03/2022 - 10/2007
4	Insulin (Novolin)FDA Link 05/2020 - 06/2009
4	Immunoglobulin G (IgG)IBA 12/2019 - 10/2014
4	Scavenger Receptors (Scavenger Receptor)IBA 01/2019 - 08/2003
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2018 - 02/2003
4	Apolipoproteins E (ApoE)IBA 10/2016 - 07/2014
4	HDL LipoproteinsIBA 12/2014 - 08/2003
4	EnzymesIBA 11/2013 - 05/2007
3	IgG Receptors (Fc gamma RI)IBA 12/2019 - 02/2015
3	LigandsIBA 01/2018 - 11/2013
3	Estrogen Receptor alphaIBA 01/2017 - 07/2010
3	Selective Estrogen Receptor Modulators (SERM)IBA 08/2014 - 01/2008
3	high density lipoprotein receptorsIBA 10/2012 - 08/2003
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2009 - 11/2005
2	N-acetylmannosamineIBA 12/2019 - 01/2018
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 12/2019 - 01/2018
2	Glycoproteins (Glycoprotein)IBA 10/2018 - 01/2011
2	Dendrimers (Dendrons)IBA 10/2016 - 04/2011
2	LDL Receptors (LDL Receptor)IBA 03/2016 - 03/2016
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2006 - 08/2003
2	Surface-Active Agents (Surfactants)IBA 01/2006 - 12/2005
2	acivicin (AT 125)IBA 03/2005 - 05/2003
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	(S)- 5- (4- hydroxy- 3,5- dimethyl- phenyl)- indan- 1- olIBA 11/2018
1	Transcription Factors (Transcription Factor)IBA 11/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Sirtuin 1IBA 01/2018
1	CollagenIBA 01/2018
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 01/2018
1	ResveratrolIBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2017
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 10/2016
1	AminesIBA 10/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2016
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2016
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 03/2016
1	Monoclonal AntibodiesIBA 01/2016
1	Protein Kinase CIBA 06/2015
1	ATP Binding Cassette Transporter 1IBA 05/2015
1	triacetyl-3-hydroxyphenyladenosineIBA 05/2015
1	Serum Amyloid P-ComponentIBA 02/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	Molsidomine (SIN 10)IBA 10/2014
1	Apolipoprotein E3IBA 09/2014

Therapy/Procedure

3	Therapeutics 01/2021 - 05/2007
3	Ligation 01/2015 - 12/2005